Purchase Order 15F06722P0000615
- Not listed
- This federal contract award is for the purchase of a QIAXCEL ADVANCED INSTRUMENT, awarded by the Northeast Area division of a civilian federal agency to the vendor Qiagen, LLC. The contract has a firm fixed price of $24,333.00 and a completion date of September 3, 2015. The contract is not set aside and is a purchase order. Qiagen, LLC is a division of the parent company Qiagen N.V., an international provider of sample and assay technologies for various government applications including...
- This federal contract award extends a service agreement with Qiagen, LLC, a subsidiary of Qiagen N.V., a global biotechnology company. The $12,063 firm fixed-price purchase order was awarded by the Pacific West Area of a civilian federal agency. The contract has a one-year period of performance, with a completion date of September 28, 2024. No set-aside designation was used. Qiagen is a long-standing provider of specialized products and services to support federal agencies' biomedical...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of Qiagen N.V. The $111,768.00 contract does not have a set-aside designation. Qiagen, a provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, is delivering products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs. Qiagen holds several...
- This $23,248.02 firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V. The contract is not set aside. Qiagen provides sample and assay technologies, molecular diagnostics, and related products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs. This award is likely part of a larger indefinite delivery...
- This is a $80,260 firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of Qiagen N.V. The contract is not set aside and has a period of performance from March 28, 2019 to April 14, 2021. Qiagen, a global provider of sample and assay technologies, has delivered a range of products and services to federal agencies, including DNA/RNA extraction kits, next-generation sequencing equipment, bioinformatics software, and other...
- This firm fixed-price purchase order contract was awarded by the Office of the Chief Operating Officer (part of the Department of Health and Human Services) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The $80,047.85 contract is for the delivery of Qiagen's sample and assay technologies, including DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, and related bioinformatics software. Qiagen has provided these types of...
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a division of Qiagen N.V., for the provision of laboratory supplies. The contract has a ceiling value of $75,149.98 and a completion date of August 30, 2018. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academic applications, and has previously supplied goods and services to various...
- This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $15,090 contract is for the supply of unspecified products or services, with a period of performance ending on August 27, 2018. Qiagen has previously provided a range of goods and services to federal agencies, including DNA/RNA extraction kits, sequencing equipment, bioinformatics software, and other...
- This is a $10,397.51 firm-fixed-price delivery order contract awarded by the Defense Health Agency to Qiagen, LLC, a division of the international firm Qiagen N.V. The contract is for the provision of medical supplies, with a period of performance through September 30, 2023. Qiagen has provided a range of products and services supporting federal biomedical research, public health, and healthcare programs, including DNA/RNA extraction kits, sequencing equipment, and bioinformatics software. The...
- This is a $13,858 firm fixed-price purchase order awarded by the Office of Acquisitions and Grants, a civilian federal agency, to Qiagen, LLC, a foreign-owned for-profit manufacturer and global provider of sample and assay technologies for molecular diagnostics, applied testing, pharmaceuticals, and academic research. The contract is for the maintenance of QIAGEN laboratory equipment. It does not have a set-aside designation and has an ultimate completion date of May 14, 2028. Qiagen is a...
This is a firm fixed price purchase order awarded by the Headquarters Division of the U.S. government to Qiagen, LLC, a division of Qiagen N.V., for a QIAXCEL CONNECT FRAGMENT ANALYZER. The award amount is $50,857.49, with a completion date of July 31, 2022. The contract does not have a set-aside designation. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics. They have provided a range of products and services to various federal agencies, including the Department of Health and Human Services, Department of Veterans Affairs, Department of Defense, Department of Justice, and more. Qiagen holds several federal indefinite delivery contracts and blanket purchase agreements to provide their specialized products and services efficiently to these agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($255) | 8/1/24 | |
| Not listed | Not listed | $51.1k | 6/24/22 |